Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ashdod
Clinical trial register · Israel

Clinical Trials in Ashdod, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2438 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2438
Studies in scope
all four open statuses
1243
Recruiting now
open to new participants
461
Lead sponsors
across recruiting studies
Top sites
Jerusalem 848 Haifa 738 Tel Aviv 691 Ramat Gan 653 Petah Tikva 619
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC6 Eli Lilly and Company6 AbbVie5 AstraZeneca5 Assuta Ashdod Hospital4
Site location
Jerusalem848 Haifa738 Tel Aviv691 Ramat Gan653 Petah Tikva619
All 102 locations
Target enrolment
to

Trials with a site in Ashdod

75 of 2438 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Ashdod, Beer Yaakov, Hadera, Haifa, Holon, Jerusalem, Kfar Saba, Petah Tikva
2026-10-26
Not yet open
Assuta Ashdod Hospital
Not applicable
100
Ashdod
2026-10-20
Not yet open
Barzilai Medical Center
Not applicable
500
Ashdod, Ashkelon, Beersheba
2026-09-01
Not yet open
Voll Non-Degradable Shoulder Spacer FIH Study
NCT07745647Massive Rotator Cuff Tears, Massive Rotator Cuff Tear
Voll Medical Technologies Ltd.
Not applicable
10
Ashdod
2026-09
Recruiting
AbbVie
Phase 2
2,000
Ashdod
2026-07-31
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Ashdod, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
2026-05-31
Recruiting
BIO|STREAM.CSP Study
NCT07393009Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices
Biotronik SE & Co. KG
Observational
1,000
Ashdod, Beersheba, Hadera, Jerusalem, Tel Aviv
2026-05-25
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Ashdod, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Ashdod, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan
2026-05-22
Recruiting
A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex
NCT06087536Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia
Omnix Medical Ltd
Phase 2
54
Ashdod, Be’er Ya‘aqov, Holon, Petah Tikva, Ramat Gan, Rishon LeZiyyon
2026-05-14
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Afula, Ashdod, Beer Yaakov, Beersheba, Hadera, Haifa, Holon, Jerusalem
2026-05-11
Recruiting
Eli Lilly and Company
Phase 2
60
Ashdod, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tsrifin
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Ashdod, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tsrifin
2026-05-04
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Ashdod, Ashkelon, Haifa, Jerusalem, Kfar Saba, Tsrifin
2026-03-26
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Afula, Ashdod, Hadera, Jerusalem, Petah Tikva, Tel Aviv
2026-02-08
Recruiting
Assuta Ashdod Hospital
Not applicable
100
Ashdod
2026-01-20
Recruiting
Contineum Therapeutics
Phase 2
324
Be’er Ya‘aqov, Kafr Saba, Petah Tikva, Ramat Gan, Rehovot, Hadera, Jerusalem, Ashdod
2026-01-08
Recruiting
Voll Degradable Shoulder Spacer FIH Study
NCT07208448Massive Rotator Cuff Tear
Voll Medical Technologies Ltd.
Not applicable
20
Ashdod, Tel Aviv
2025-12-09
Recruiting
Eli Lilly and Company
Phase 3
7,140
Ashdod, Ashkelon, Beersheba, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva
2025-12-01
Recruiting
Genmab
Phase 3
660
Haifa, Holon, Jerusalem, Nahariya, Ashdod
2025-11-28
Recruiting
AbbVie
Phase 2
180
Kefar Sava, Ashdod, Ramat Gan, Haifa, Jerusalem
2025-11-25
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Kfar Saba, Petah Tikva, Jerusalem, Ashdod
2025-11-03
Recruiting
GlaxoSmithKline
Phase 2
363
Ashdod, Ashkelon, Beersheba, Haifa, Jerusalem, Kfar Saba, Koranit, Petah Tikva
2025-10-30
Recruiting
Janssen Research & Development, LLC
Phase 2/3
1,092
Afula, Ashdod, Be’er Ya‘aqov, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan
2025-10-03
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Afula, Ashdod, Be’er Ya‘aqov, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan
2025-10-01
Recruiting
AstraZeneca
Phase 3
800
Ashdod, Hadera, Haifa, Holon, Jerusalem, Nahariya, Ramat Gan, Safed
2025-08-01
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Afula, Ashdod, Ashkelon, Haifa, Herzelia, Holon, Jerusalem, Nahariya
2025-07-22
Active, closed
Compugen Ltd
Phase 1/2
60
Ashdod, Haifa, Holon, Jerusalem, Ramat Gan
2025-07-21
Recruiting
Eli Lilly and Company
Phase 3
350
Ashdod, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
290
Ashdod, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, Tsrifin
2025-06-26
Active, closed
AbbVie
Phase 3
573
Petah Tikva, Tsrifin, Ashdod, Beersheba, Ramat Gan, Tel Aviv, Haifa
2025-06-17
Not yet open
Iron Deficiency in Pediatric Celiac Disease: Diet vs. Iron Supplementation Trial
NCT06921343Celiac Disease in Children, Iron Deficiency
Kaplan Medical Center
Not applicable
150
Ashdod, Haifa, Kfar Saba, Petah Tikva, Rehovot
2025-04
Active, closed
An Ophthalmic Safety Study in Patients With Breast Cancer
NCT06767462Ophthalmic Safety in Patients With Breast Cancer
AstraZeneca
Observational
160
Ashdod, Nahariya
2025-03-05
Recruiting
AstraZeneca
Phase 3
5,000
Afula, Ashdod, Be’er Ya‘aqov, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva
2025-03-03
Recruiting
Takeda
Phase 3
1,088
Ashdod, Ashkelon, Haifa, Nahariya, Ramat Gan, Tel Aviv
2025-03-03
Recruiting
Novartis Pharmaceuticals
Phase 2
20
Ashdod, Hadera, Haifa, Nahariya
2025-02-21
Active, closed
Amorphical Ltd.
Phase 2
62
Ashdod, Haifa, Jerusalem, Petah Tikva, Ashkelon, Beersheba, Ramat Gan, Rehovot
2024-12-15
Recruiting
Bayer
Phase 3
444
Ashdod, Beersheba, Jerusalem, Tel Aviv
2024-08-28
Recruiting
Assuta Ashdod Hospital
Observational
150
Ashdod
2024-07-01
Active, closed
Takeda
Phase 2
213
Ashdod, Beersheba, Jerusalem, Ramat Gan
2024-03-29
Recruiting
GlaxoSmithKline
Phase 3
864
Ashdod, Haifa, Jerusalem, Tel Aviv
2024-03-21
Recruiting
Takeda
Phase 2
268
Ashdod, Beersheba, Jerusalem, Kfar Saba, Ramat Gan
2024-03-05
Active, closed
DualityBio Inc.
Phase 3
541
Ashdod, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan, Rehovot, Tel Aviv
2024-01-18
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Ashdod, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
2023-12-28
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Tel HaShomer, Ashdod, Haifa, Jerusalem, Nahariya, Tel Aviv
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Ashdod, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
2023-12-12
Active, closed
BeOne Medicines
Phase 3
652
Ashdod, Haifa, Jerusalem, Tel Aviv
2023-11-11
Not yet open
Use of Misoprostol in Hysteroscopic Myomectomy
NCT06049745Hysteroscopic Myomectomy
Assuta Ashdod Hospital
Phase 4
200
Ashdod
2023-11
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Ashdod, Ashkelon, Beersheba, Be’er Ya‘aqov, Haifa, Jerusalem, Kfar Saba, Petach Tiqwa
2023-06-28
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Ashdod, Beer Ya'Aqov, Hadera, Haifa, Jerusalem, Petah Tikva, Ramat Gan
2023-06-22
Recruiting
Carmel Medical Center
Not applicable
264
Ashdod, Beersheba, Be’er Ya‘aqov, Haifa, Petah Tikva, Rehovot, Safed, Tel Aviv
2023-04-17
Recruiting
AstraZeneca
Phase 3
4,300
Afula, Ashdod, Haifa, Jerusalem, Kfar Saba, Nahariya, Ramat Gan, Rehovot
2023-03-31
Active, closed
Stemline Therapeutics, Inc.
Phase 1/2
435
Ashdod, Haifa, Jerusalem, Petah Tikva, Ramat Gan
2023-01-24
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Ashdod, Jerusalem, Kfar Saba, Nahariya, Ramat Gan, Tel Aviv
2022-10-14
Active, closed
Study of Sonrotoclax (BGB-11417) Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma
NCT05471843Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma
DrugSonrotoclax
BeOne Medicines
Phase 1/2
125
Ashdod, Jerusalem
2022-09-05
Active, closed
AstraZeneca
Phase 3
341
Afula, Ashdod, Be’er Ya‘aqov, Hadera, Jerusalem, Tel Aviv
2022-08-03
Active, closed
BeOne Medicines
Phase 3
799
Ashdod, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2022-03-10
Recruiting
Cordio Medical
Observational
500
Ashdod, Beersheba, Haifa, Jerusalem, Nahariya, Tel Aviv, Tiberias
2022-02-11
Active, closed
BioProtect
Observational
80
Ashdod, Petah Tikva
2022-01-01
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Ashdod, Haifa, Jerusalem, Tel Aviv
2021-12-10
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Ashdod, Holon, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Sefad, Tsrifin
2021-11-23
Active, closed
Gilead Sciences
Phase 3
603
Ashdod, Beersheba, Jerusalem, Rehovot, Tel Aviv, Tzrifin
2021-11-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Ashdod, Beersheba, Haifa, Ramat Gan, Tel Aviv
2021-06-18
Active, closed
Geron Corporation
Phase 3
327
Rehovot, Tsrifin, Jerusalem, Ashdod, Ashkelon, Beersheba, Haifa
2021-04-12
Active, closed
Hoffmann-La Roche
Phase 2
303
Ashdod, Jerusalem, Kfar Saba
2020-11-27
Active, closed
Acerta Pharma BV
Phase 3
611
Afula, Ashdod, Beersheba, Haifa, Holon, Jerusalem, Nahariya, Petah Tikva
2020-10-08
Active, closed
ADC Therapeutics S.A.
Phase 3
440
Ashdod, Beersheba, Be’er Ya‘aqov, Haifa, Petah Tikva, Tel Aviv
2020-09-16
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Ashdod, Beersheba, Petah Tikva, Tel Aviv
2020-09-03
Active, closed
AbbVie
Phase 3
330
Tsrifin, Afula, Haifa, Jerusalem, Nahariya, Ashdod, Ramat Gan, Tel Aviv
2020-08-31
Recruiting
Karyopharm Therapeutics Inc
Phase 2
127
Afula, Ashdod, Haifa, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv, Ashkelon
2020-07-01
Active, closed
Sanofi
Phase 3
337
Ashdod, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
2020-06-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Afula, Ashdod, Beersheba, Haifa, Jerusalem, Kfar Saba, Nazareth, Petah Tikva
2018-12-27
Active, closed
AbbVie
Phase 3
265
Haifa, Jerusalem, Ashdod, Beersheba, Ramat Gan, Tel Aviv, Petah Tikva
2018-10-22
Active, closed
V-Wave Ltd
Not applicable
605
Ashdod, Be’er Ya‘aqov, Jerusalem, Ramat Gan, Rehovot, Tel Aviv, Tiberias
2018-09-19
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Ashdod, Beersheba, Holon, Jerusalem, Kfar Saba, Petah Tikva, Rehovot, Tel HaShomer
2018-05-14
Rows per page Showing 1–75 of 75
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 30 October 2026. https://priyalifescience.com/clinical-trials-israel/city/ashdod

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,438 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 75 of those studies with a site in Ashdod.

How many clinical trials are recruiting in Ashdod?

39 of the 75 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 6 have not yet opened recruitment, 30 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ashdod), 75 studies
PhaseStudiesRecruitingShare
Phase 3402153.3%
Phase 2151120%
Not applicable8310.7%
Observational638%
Phase 1/2304%
Phase 2/3212.7%
Phase 4101.3%

Most active sponsors

Lead sponsors with the most studies (Ashdod)
Lead sponsorStudiesRecruiting
Eli Lilly and Company66
Janssen Research & Development, LLC65
AbbVie52
AstraZeneca53
Assuta Ashdod Hospital42
BeOne Medicines30
Regeneron Pharmaceuticals33
Takeda32
Bayer21
Biotronik SE & Co. KG21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.